Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 3941 entries
Sorted by: Best Match Show Resources per page
5704Validation of the SCAI definition of periprocedural myocardial infarction for prediction of one-year mortality following elective percutaneous coronary interventions

Stem career interventions

Ndrepepa G.
GSID: dLeSkuMOhc8J
KC Koskinas, G Ndrepepa, L Raeber… - European Heart …, 2017 - academic.oup.com

Background: The clinical significance of myocardial injury following percutaneous coronary interventions (PCI) remains controversial, and the magnitude of cardiac troponin (cTn) elevation portending prognostic relevance has not been clearly defined. The Society for Cardiovascular Angiography and Interventions (SCAI) proposed...

Cite
Koskinas, K. C., Ndrepepa, G., Raeber, L., Kufner, S., Karagiannis, A., Zanchin, T., ... & Kastrati, A. (2017). 5704Validation of the SCAI definition of periprocedural myocardial infarction for prediction of one-year mortality following elective percutaneous coronary interventions. European Heart Journal, 38(suppl_1).
Koskinas, K. C., et al. "5704Validation of the SCAI definition of periprocedural myocardial infarction for prediction of one-year mortality following elective percutaneous coronary interventions." European Heart Journal 38.suppl_1 (2017).
Copy Download .nbib Format: MLA
Late stent fracture - A potential role of left ventricular dilatation.

Journal of the Saudi Heart Association

Al Mamary A, Dariol G, Napodano M.
PMID: 24954989
J Saudi Heart Assoc. 2014 Jul;26(3):162-5. doi: 10.1016/j.jsha.2014.02.001. Epub 2014 Feb 10.

BACKGROUND: Coronary stent fracture is an under-recognized event but one that has been reported frequently in the drug-eluting stent era. Most reported cases of stent fracture occurred within days to two years after implantation, and are related to stent...

Cite
Al Mamary A, Dariol G, Napodano M. Late stent fracture - A potential role of left ventricular dilatation. J Saudi Heart Assoc. 2014;26(3):162-5doi: 10.1016/j.jsha.2014.02.001.
Al Mamary, A., Dariol, G., & Napodano, M. (2014). Late stent fracture - A potential role of left ventricular dilatation. Journal of the Saudi Heart Association, 26(3), 162-5. https://doi.org/10.1016/j.jsha.2014.02.001
Al Mamary, Ahmed, et al. "Late stent fracture - A potential role of left ventricular dilatation." Journal of the Saudi Heart Association vol. 26,3 (2014): 162-5. doi: https://doi.org/10.1016/j.jsha.2014.02.001
Al Mamary A, Dariol G, Napodano M. Late stent fracture - A potential role of left ventricular dilatation. J Saudi Heart Assoc. 2014 Jul;26(3):162-5. doi: 10.1016/j.jsha.2014.02.001. Epub 2014 Feb 10. PMID: 24954989; PMCID: PMC4062758.
Copy Download .nbib Format: NLM
Potential impact of silymarin in combination with chlorogenic acid and/or melatonin in combating cardiomyopathy induced by carbon tetrachloride.

Saudi journal of biological sciences

Al-Rasheed NM, Al-Rasheed NM, Faddah LM, Mohamed AM, Mohammad RA, Al-Amin M.
PMID: 24955012
Saudi J Biol Sci. 2014 Jul;21(3):265-74. doi: 10.1016/j.sjbs.2013.09.006. Epub 2013 Sep 17.

The aim of this study was to investigate the effective role of silymarin either alone or in combination with chlorogenic acid and/or melatonin against the toxic impact of carbon tetrachloride (CCl4) induced cardiac infarction. CCl4 (l.2 ml/kg body weight)...

Cite
Al-Rasheed NM, Al-Rasheed NM, Faddah LM, et al. Potential impact of silymarin in combination with chlorogenic acid and/or melatonin in combating cardiomyopathy induced by carbon tetrachloride. Saudi J Biol Sci. 2013;21(3):265-74doi: 10.1016/j.sjbs.2013.09.006.
Al-Rasheed, N. M., Al-Rasheed, N. M., Faddah, L. M., Mohamed, A. M., Mohammad, R. A., & Al-Amin, M. (2014). Potential impact of silymarin in combination with chlorogenic acid and/or melatonin in combating cardiomyopathy induced by carbon tetrachloride. Saudi journal of biological sciences, 21(3), 265-74. https://doi.org/10.1016/j.sjbs.2013.09.006
Al-Rasheed, Nouf M, et al. "Potential impact of silymarin in combination with chlorogenic acid and/or melatonin in combating cardiomyopathy induced by carbon tetrachloride." Saudi journal of biological sciences vol. 21,3 (2014): 265-74. doi: https://doi.org/10.1016/j.sjbs.2013.09.006
Al-Rasheed NM, Al-Rasheed NM, Faddah LM, Mohamed AM, Mohammad RA, Al-Amin M. Potential impact of silymarin in combination with chlorogenic acid and/or melatonin in combating cardiomyopathy induced by carbon tetrachloride. Saudi J Biol Sci. 2014 Jul;21(3):265-74. doi: 10.1016/j.sjbs.2013.09.006. Epub 2013 Sep 17. PMID: 24955012; PMCID: PMC4061402.
Copy Download .nbib Format: NLM
Sensitive Detection of Cardiac Biomarkers Using a Magnetic Microbead Immunoassay.

Analytical methods : advancing methods and applications

Woolley CF, Hayes MA.
PMID: 26527562
Anal Methods. 2015 Oct 21;7(20):8632-8639. doi: 10.1039/C5AY01071C. Epub 2015 Aug 20.

To achieve improved sensitivity in cardiac biomarker detection, a batch incubation magnetic microbead immunoassay was developed and tested on three separate human protein targets: myoglobin, heart-type fatty acid binding protein, and cardiac troponin I. A sandwich immunoassay was performed...

Cite
Woolley CF, Hayes MA. Sensitive Detection of Cardiac Biomarkers Using a Magnetic Microbead Immunoassay. Anal Methods. 2015;7(20):8632-8639doi: 10.1039/C5AY01071C.
Woolley, C. F., & Hayes, M. A. (2015). Sensitive Detection of Cardiac Biomarkers Using a Magnetic Microbead Immunoassay. Analytical methods : advancing methods and applications, 7(20), 8632-8639. https://doi.org/10.1039/C5AY01071C
Woolley, Christine F, and Hayes, Mark A. "Sensitive Detection of Cardiac Biomarkers Using a Magnetic Microbead Immunoassay." Analytical methods : advancing methods and applications vol. 7,20 (2015): 8632-8639. doi: https://doi.org/10.1039/C5AY01071C
Woolley CF, Hayes MA. Sensitive Detection of Cardiac Biomarkers Using a Magnetic Microbead Immunoassay. Anal Methods. 2015 Oct 21;7(20):8632-8639. doi: 10.1039/C5AY01071C. Epub 2015 Aug 20. PMID: 26527562; PMCID: PMC4625556.
Copy Download .nbib Format: NLM
Ginseng total saponin attenuates myocardial injury via anti-oxidative and anti-inflammatory properties.

Journal of ginseng research

Aravinthan A, Kim JH, Antonisamy P, Kang CW, Choi J, Kim NS, Kim JH.
PMID: 26199551
J Ginseng Res. 2015 Jul;39(3):206-12. doi: 10.1016/j.jgr.2014.12.001. Epub 2014 Dec 23.

BACKGROUND: Ginseng total saponin (GTS) contains various ginsenosides. These ginsenosides are widely used for treating cardiovascular diseases in Asian communities. The aim of this study was to study the effects of GTS on cardiac injury after global ischemia and...

Cite
Aravinthan A, Kim JH, Antonisamy P, et al. Ginseng total saponin attenuates myocardial injury via anti-oxidative and anti-inflammatory properties. J Ginseng Res. 2014;39(3):206-12doi: 10.1016/j.jgr.2014.12.001.
Aravinthan, A., Kim, J. H., Antonisamy, P., Kang, C. W., Choi, J., Kim, N. S., & Kim, J. H. (2015). Ginseng total saponin attenuates myocardial injury via anti-oxidative and anti-inflammatory properties. Journal of ginseng research, 39(3), 206-12. https://doi.org/10.1016/j.jgr.2014.12.001
Aravinthan, Adithan, et al. "Ginseng total saponin attenuates myocardial injury via anti-oxidative and anti-inflammatory properties." Journal of ginseng research vol. 39,3 (2015): 206-12. doi: https://doi.org/10.1016/j.jgr.2014.12.001
Aravinthan A, Kim JH, Antonisamy P, Kang CW, Choi J, Kim NS, Kim JH. Ginseng total saponin attenuates myocardial injury via anti-oxidative and anti-inflammatory properties. J Ginseng Res. 2015 Jul;39(3):206-12. doi: 10.1016/j.jgr.2014.12.001. Epub 2014 Dec 23. PMID: 26199551; PMCID: PMC4506374.
Copy Download .nbib Format: NLM
Diverse Phenotypic Expression of Cardiomyopathies in a Family with TNNI3 p.Arg145Trp Mutation.

Korean circulation journal

Hwang JW, Jang MA, Jang SY, Seo SH, Seong MW, Park SS, Ki CS, Kim DK.
PMID: 28382084
Korean Circ J. 2017 Mar;47(2):270-277. doi: 10.4070/kcj.2016.0213. Epub 2017 Mar 13.

Genetic diagnosis of cardiomyopathies is challenging, due to the marked genetic and allelic heterogeneity and the lack of knowledge of the mutations that lead to clinical phenotypes. Here, we present the case of a large family, in which a...

Cite
Hwang JW, Jang MA, Jang SY, et al. Diverse Phenotypic Expression of Cardiomyopathies in a Family with TNNI3 p.Arg145Trp Mutation. Korean Circ J. 2017;47(2):270-277doi: 10.4070/kcj.2016.0213.
Hwang, J. W., Jang, M. A., Jang, S. Y., Seo, S. H., Seong, M. W., Park, S. S., Ki, C. S., & Kim, D. K. (2017). Diverse Phenotypic Expression of Cardiomyopathies in a Family with TNNI3 p.Arg145Trp Mutation. Korean circulation journal, 47(2), 270-277. https://doi.org/10.4070/kcj.2016.0213
Hwang, Ji-Won, et al. "Diverse Phenotypic Expression of Cardiomyopathies in a Family with TNNI3 p.Arg145Trp Mutation." Korean circulation journal vol. 47,2 (2017): 270-277. doi: https://doi.org/10.4070/kcj.2016.0213
Hwang JW, Jang MA, Jang SY, Seo SH, Seong MW, Park SS, Ki CS, Kim DK. Diverse Phenotypic Expression of Cardiomyopathies in a Family with TNNI3 p.Arg145Trp Mutation. Korean Circ J. 2017 Mar;47(2):270-277. doi: 10.4070/kcj.2016.0213. Epub 2017 Mar 13. PMID: 28382084; PMCID: PMC5378035.
Copy Download .nbib Format: NLM
Cardiac troponin trends and severity in chronic obstructive pulmonary disease exacerbation: Are limits properly associated for Intensive Care Unit outcome?.

Lung India : official organ of Indian Chest Society

Yıldırım F, Esquinas AM.
PMID: 27625469
Lung India. 2016 Sep-Oct;33(5):583-4. doi: 10.4103/0970-2113.189007.

No abstract available.

Cite
Yıldırım F, Esquinas AM. Cardiac troponin trends and severity in chronic obstructive pulmonary disease exacerbation: Are limits properly associated for Intensive Care Unit outcome?. Lung India. 2016;33(5):583-4doi: 10.4103/0970-2113.189007.
Yıldırım, F., & Esquinas, A. M. (2016). Cardiac troponin trends and severity in chronic obstructive pulmonary disease exacerbation: Are limits properly associated for Intensive Care Unit outcome?. Lung India : official organ of Indian Chest Society, 33(5), 583-4. https://doi.org/10.4103/0970-2113.189007
Yıldırım, Fatma, and Esquinas, Antonio M. "Cardiac troponin trends and severity in chronic obstructive pulmonary disease exacerbation: Are limits properly associated for Intensive Care Unit outcome?." Lung India : official organ of Indian Chest Society vol. 33,5 (2016): 583-4. doi: https://doi.org/10.4103/0970-2113.189007
Yıldırım F, Esquinas AM. Cardiac troponin trends and severity in chronic obstructive pulmonary disease exacerbation: Are limits properly associated for Intensive Care Unit outcome?. Lung India. 2016 Sep-Oct;33(5):583-4. doi: 10.4103/0970-2113.189007. PMID: 27625469; PMCID: PMC5006355.
Copy Download .nbib Format: NLM
Modulatory effect of semelil (ANGIPARS™) on isoproterenol induced cardiac injury.

EXCLI journal

Joukar S, Najafipour H, Mirzaeipour F, Nasri H, Ahmadi MY, Badinloo M.
PMID: 26417221
EXCLI J. 2013 Feb 19;12:122-9. eCollection 2013.

Administration of semelil (ANGIPARS™) has been successful in the treatment of diabetic foot ulcer. Considering the improvement of blood flow and anti-inflammatory effect that are attributed to this drug, we investigated its effect on cardiovascular performance in rabbits with...

Cite
Joukar S, Najafipour H, Mirzaeipour F, et al. Modulatory effect of semelil (ANGIPARS™) on isoproterenol induced cardiac injury. EXCLI J. 2013;12:122-9
Joukar, S., Najafipour, H., Mirzaeipour, F., Nasri, H., Ahmadi, M. Y., & Badinloo, M. (2013). Modulatory effect of semelil (ANGIPARS™) on isoproterenol induced cardiac injury. EXCLI journal, 12122-9.
Joukar, Siyavash, et al. "Modulatory effect of semelil (ANGIPARS™) on isoproterenol induced cardiac injury." EXCLI journal vol. 12 (2013): 122-9.
Joukar S, Najafipour H, Mirzaeipour F, Nasri H, Ahmadi MY, Badinloo M. Modulatory effect of semelil (ANGIPARS™) on isoproterenol induced cardiac injury. EXCLI J. 2013 Feb 19;12:122-9. eCollection 2013. PMID: 26417221; PMCID: PMC4531780.
Copy Download .nbib Format: NLM
Modeling Ca.

Frontiers in physiology

Zot HG, Hasbun JE.
PMID: 27708586
Front Physiol. 2016 Sep 21;7:406. doi: 10.3389/fphys.2016.00406. eCollection 2016.

To explain disparate decay rates of cytosolic Ca

Cite
Zot HG, Hasbun JE. Modeling Ca. Front Physiol. 2016;7:406doi: 10.3389/fphys.2016.00406.
Zot, H. G., & Hasbun, J. E. (2016). Modeling Ca. Frontiers in physiology, 7406. https://doi.org/10.3389/fphys.2016.00406
Zot, Henry G, and Hasbun, Javier E. "Modeling Ca." Frontiers in physiology vol. 7 (2016): 406. doi: https://doi.org/10.3389/fphys.2016.00406
Zot HG, Hasbun JE. Modeling Ca. Front Physiol. 2016 Sep 21;7:406. doi: 10.3389/fphys.2016.00406. eCollection 2016. PMID: 27708586; PMCID: PMC5030304.
Copy Download .nbib Format: NLM
Validation, optimisation, and application data in support of the development of a targeted selected ion monitoring assay for degraded cardiac troponin T.

Data in brief

Streng AS, de Boer D, Bouwman FG, Mariman EC, Scholten A, van Dieijen-Visser MP, Wodzig WK.
PMID: 26977445
Data Brief. 2016 Mar 03;7:397-405. doi: 10.1016/j.dib.2016.02.051. eCollection 2016 Jun.

Cardiac troponin T (cTnT) fragmentation in human serum was investigated using a newly developed targeted selected ion monitoring assay, as described in the accompanying article: "Development of a targeted selected ion monitoring assay for the elucidation of protease induced...

Cite
Streng AS, de Boer D, Bouwman FG, et al. Validation, optimisation, and application data in support of the development of a targeted selected ion monitoring assay for degraded cardiac troponin T. Data Brief. 2016;7:397-405doi: 10.1016/j.dib.2016.02.051.
Streng, A. S., de Boer, D., Bouwman, F. G., Mariman, E. C., Scholten, A., van Dieijen-Visser, M. P., & Wodzig, W. K. (2016). Validation, optimisation, and application data in support of the development of a targeted selected ion monitoring assay for degraded cardiac troponin T. Data in brief, 7397-405. https://doi.org/10.1016/j.dib.2016.02.051
Streng, Alexander S, et al. "Validation, optimisation, and application data in support of the development of a targeted selected ion monitoring assay for degraded cardiac troponin T." Data in brief vol. 7 (2016): 397-405. doi: https://doi.org/10.1016/j.dib.2016.02.051
Streng AS, de Boer D, Bouwman FG, Mariman EC, Scholten A, van Dieijen-Visser MP, Wodzig WK. Validation, optimisation, and application data in support of the development of a targeted selected ion monitoring assay for degraded cardiac troponin T. Data Brief. 2016 Mar 03;7:397-405. doi: 10.1016/j.dib.2016.02.051. eCollection 2016 Jun. PMID: 26977445; PMCID: PMC4782000.
Copy Download .nbib Format: NLM
High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages.

Annals of translational medicine

Galli C, Lippi G.
PMID: 27500158
Ann Transl Med. 2016 Jul;4(13):257. doi: 10.21037/atm.2016.07.04.

Very seldom, if ever, a single laboratory test has provided such a paradigm shift in the managed care as cardiac troponin (cTn) testing. More than twenty years of improvements in test design and analytical features have contributed to revolutionize...

Cite
Galli C, Lippi G. High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages. Ann Transl Med. 2016;4(13):257doi: 10.21037/atm.2016.07.04.
Galli, C., & Lippi, G. (2016). High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages. Annals of translational medicine, 4(13), 257. https://doi.org/10.21037/atm.2016.07.04
Galli, Claudio, and Lippi, Giuseppe. "High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages." Annals of translational medicine vol. 4,13 (2016): 257. doi: https://doi.org/10.21037/atm.2016.07.04
Galli C, Lippi G. High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages. Ann Transl Med. 2016 Jul;4(13):257. doi: 10.21037/atm.2016.07.04. PMID: 27500158; PMCID: PMC4958731.
Copy Download .nbib Format: NLM
Arterial Velocity Pulse Index as a Novel Marker of Atherosclerosis Using Pulse Wave Analysis on High Sensitivity Troponin T in Hypertensive Patients.

Cardiology research

Hitsumoto T.
PMID: 28515820
Cardiol Res. 2017 Apr;8(2):36-43. doi: 10.14740/cr545w. Epub 2017 May 03.

BACKGROUND: The arterial velocity pulse index (AVI) is explored as a novel marker of atherosclerosis using pulse wave analysis in clinical settings. Recent clinical studies have reported that the level of high-sensitivity troponin T (hs-cTnT) is an important biomarker...

Cite
Hitsumoto T. Arterial Velocity Pulse Index as a Novel Marker of Atherosclerosis Using Pulse Wave Analysis on High Sensitivity Troponin T in Hypertensive Patients. Cardiol Res. 2017;8(2):36-43doi: 10.14740/cr545w.
Hitsumoto, T. (2017). Arterial Velocity Pulse Index as a Novel Marker of Atherosclerosis Using Pulse Wave Analysis on High Sensitivity Troponin T in Hypertensive Patients. Cardiology research, 8(2), 36-43. https://doi.org/10.14740/cr545w
Hitsumoto, Takashi. "Arterial Velocity Pulse Index as a Novel Marker of Atherosclerosis Using Pulse Wave Analysis on High Sensitivity Troponin T in Hypertensive Patients." Cardiology research vol. 8,2 (2017): 36-43. doi: https://doi.org/10.14740/cr545w
Hitsumoto T. Arterial Velocity Pulse Index as a Novel Marker of Atherosclerosis Using Pulse Wave Analysis on High Sensitivity Troponin T in Hypertensive Patients. Cardiol Res. 2017 Apr;8(2):36-43. doi: 10.14740/cr545w. Epub 2017 May 03. PMID: 28515820; PMCID: PMC5421484.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 3941 entries